UPDATED: Vytorin Gets FDA Panel Nod for Some CKD Patients
Internal Medicine News Digital Network
Vytorin should be approved for preventing major vascular events in patients who have chronic kidney disease but are not on dialysis, according to a unanimous vote by a Food and Drug Administration advisory panel. The panel also voted 10-6, however, ...
FDA Advisory Committee Unanimously Recommends Approval of Merck's VYTORIN(R ...MarketWatch (press release)
Advisers Back Merck Drug for Some Kidney PatientsFox News
Advisers back Merck drug for some kidney patientsReuters
Forbes -MedPage Today -TheHeart.Org
all 61 news articles »